A detailed history of Integral Health Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 10,000 shares of LLY stock, worth $7.67 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$7.67 Million
Previous $9.05 Million 2.14%
% of portfolio
1.04%
Previous 0.87%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $1.45 Million - $1.82 Million
-2,000 Reduced 16.67%
10,000 $9.05 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $9.48 Million - $12.7 Million
-16,000 Reduced 57.14%
12,000 $9.34 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.58 Million - $1.86 Million
3,000 Added 12.0%
28,000 $16.3 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $2.17 Million - $3 Million
-5,000 Reduced 16.67%
25,000 $13.4 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $10.5 Million - $14.1 Million
30,000 New
30,000 $14.1 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $14.2 Million - $16.2 Million
-48,059 Reduced 65.78%
25,000 $8.08 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $20.4 Million - $23.9 Million
73,059 New
73,059 $23.7 Million
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $8.22 Million - $10.6 Million
-50,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $6.52 Million - $8.63 Million
50,000 New
50,000 $8.44 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $5.12 Million - $5.92 Million
-35,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $4.77 Million - $5.75 Million
35,000 New
35,000 $5.75 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $5.95 Million - $7.37 Million
-50,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $5.35 Million - $6.62 Million
50,000 New
50,000 $6.57 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $728B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.